CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 9,000 shares (option exercise)
- 4 Open-market sale Director sold 800 shares at $30.15 ($24,120)
- 4 Open-market sale Director sold 14,619 shares at an average $30.09 ($439,821)
- 4 Open-market sale Director sold 7,461 shares at an average $30.06 ($224,251)
- 4 Open-market sale Director sold 100 shares at $30.00 ($3,000)
- 4 Open-market sale Director sold 3,500 shares at $30.00 ($105,000)
- 4 Open-market sale Director sold 711 shares at $30.03 ($21,351)
- 4 Open-market sale Director sold 70,828 shares at an average $30.41 ($2,154,007)
- 4 Open-market sale Chief Medical Officer sold 100 shares at $30.25 ($3,025)
- 4 Open-market sale Chief Medical Officer sold 3,900 shares at $30.25 ($117,975)
- 4 Open-market sale Director sold 46,906 shares at an average $30.25 ($1,418,687)
- 4 Open-market sale Director sold 58,829 shares at an average $30.45 ($1,791,095)
- 4 Open-market sale Director sold 51,854 shares at an average $30.87 ($1,600,944)
- 4 Open-market sale Director sold 3,500 shares at $29.50 ($103,250)
- 4 Open-market sale Director sold 30,664 shares at an average $33.05 ($1,013,320)
- 4 Exercise or conversion President and CEO acquired 5,500 shares (option exercise)
- 4 Exercise or conversion COO, CFO acquired 5,000 shares (option exercise)
- 4 Open-market sale SVP, Regulatory Affairs and QA sold 2,896 shares at $33.78 ($97,814)
- 4 Open-market sale Director sold 80,491 shares at an average $33.89 ($2,727,673)
Page 5 of 10 · 190 filings